TBFA
REGN icon

Three Bearings Fiduciary Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Three Bearings Fiduciary Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624 Hold
1
– – ﹤0.01% 294
2026
Q1 		$773 Hold
1
– – ﹤0.01% 295
2025
Q4 		$742 Buy
+1
New +$679 ﹤0.01% 334

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Three Bearings Fiduciary Advisors's REGN Position: Q2 2026 in Review

Three Bearings Fiduciary Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 1 share worth $624. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Three Bearings Fiduciary Advisors first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $773 in Q1 2026. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Three Bearings Fiduciary Advisors held 1 share of Regeneron Pharmaceuticals worth $624 as of Q2 2026.
  • Three Bearings Fiduciary Advisors left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Three Bearings Fiduciary Advisors's portfolio in Q2 2026, its #294 holding.
  • Three Bearings Fiduciary Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Three Bearings Fiduciary Advisors's Regeneron Pharmaceuticals position peaked at $773 in Q1 2026.
  • 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Three Bearings Fiduciary Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.